128 related articles for article (PubMed ID: 18770864)
21. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
22. [Study of hypermethylation of SOCS gene in typical myeloproliferative disease].
Qin W; Li LL; Lu HN; Huang BB; Xiu B; Bo LJ; Gao QM; Zhang WJ; Fu JF
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):772-6. PubMed ID: 22339915
[TBL] [Abstract][Full Text] [Related]
23. Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsies.
Weise LM; Harter PN; Eibach S; Braczynski AK; Dunst M; Rieger J; Bähr O; Hattingen E; Steinbach JP; Plate KH; Seifert V; Mittelbronn M
Stereotact Funct Neurosurg; 2014; 92(3):129-39. PubMed ID: 24776650
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
25. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
26. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
[TBL] [Abstract][Full Text] [Related]
27. Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.
Sunwoo L; Choi SH; Park CK; Kim JW; Yi KS; Lee WJ; Yoon TJ; Song SW; Kim JE; Kim JY; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Chang KH
J Magn Reson Imaging; 2013 Feb; 37(2):351-8. PubMed ID: 23023975
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
[TBL] [Abstract][Full Text] [Related]
29. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.
Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S
Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.
Martinez R; Schackert G; Esteller M
J Neurooncol; 2007 Apr; 82(2):133-9. PubMed ID: 17048097
[TBL] [Abstract][Full Text] [Related]
32. Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute-on-chronic hepatitis B liver failure.
Zhang JJ; Fan YC; Zhang ZH; Han J; Wang LY; Li T; Zhang F; Yin YP; Hu LH; Yang Y; Sun FK; Wang K
J Viral Hepat; 2015 Mar; 22(3):307-17. PubMed ID: 25045829
[TBL] [Abstract][Full Text] [Related]
33. Alterations of SOCS1 and SOCS3 transcript levels, but not promoter methylation levels in subcutaneous adipose tissues in obese women.
Emamgholipour S; Esmaeili F; Shabani M; Hasanpour SZ; Pilehvari M; Zabihi-Mahmoudabadi H; Motevasseli M; Shanaki M
BMC Endocr Disord; 2023 Jan; 23(1):7. PubMed ID: 36609306
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation.
Fu X; Song X; Li Y; Tan D; Liu G
Mol Med Rep; 2016 Jan; 13(1):301-8. PubMed ID: 26573490
[TBL] [Abstract][Full Text] [Related]
35. Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment.
Zhang JJ; Fan YC; Zhao ZH; Yang Y; Dou CY; Gao S; Wang K
Cell Mol Immunol; 2014 Jul; 11(4):396-404. PubMed ID: 24727541
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Modification of MicroRNA-219-1 and Its Association with Glioblastoma Multiforme.
Ghasemi A; Mohammadi A; Fallah S
Biochemistry (Mosc); 2021 Apr; 86(4):420-432. PubMed ID: 33941064
[TBL] [Abstract][Full Text] [Related]
37. Expression of SOCS3 throughout liver regeneration is not regulated by DNA methylation.
Guo G; Xia J; Bao J; Sun HQ; Shi YJ; Bu H
Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):401-6. PubMed ID: 22893467
[TBL] [Abstract][Full Text] [Related]
38. Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas.
Buslei R; Kreutzer J; Hofmann B; Schmidt V; Siebzehnrübl F; Hahnen E; Eyupoglu IY; Fahlbusch R; Blümcke I
Acta Neuropathol; 2006 Mar; 111(3):264-71. PubMed ID: 16421738
[TBL] [Abstract][Full Text] [Related]
39. Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme.
Cheray M; Etcheverry A; Jacques C; Pacaud R; Bougras-Cartron G; Aubry M; Denoual F; Peterlongo P; Nadaradjane A; Briand J; Akcha F; Heymann D; Vallette FM; Mosser J; Ory B; Cartron PF
Mol Cancer; 2020 Feb; 19(1):36. PubMed ID: 32098627
[TBL] [Abstract][Full Text] [Related]
40. The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemia.
Födermayr M; Zach O; Huber M; Machherndl-Spandl S; Wölfl S; Bösmüller HC; Hasenschwandtner S; Burgstaller S; Krieger O; Lutz D; Weltermann A; Hauser H
Leuk Res; 2012 May; 36(5):588-90. PubMed ID: 22325365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
